Pharmaron Beijing Co., Ltd. (SHE:300759)
China flag China · Delayed Price · Currency is CNY
47.98
-2.92 (-5.74%)
Aug 21, 2026, 3:04 PM CST

Pharmaron Beijing Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Pharmaron Beijing stock has a consensus rating of "Buy" and an average price target of ¥47.08. The average 1-year stock price forecast is 1.88% lower than the current stock price, while the lowest is ¥33.80 (-29.55%) and the highest is ¥66.94 (+39.52%).

Price Target: ¥47.08 (-1.88%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price¥33.80¥47.08¥42.80¥66.94
Change-29.55%-1.88%-10.80%+39.52%

Analyst Ratings

The average analyst rating for Pharmaron Beijing stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy788766
Buy332233
Hold222222
Sell111111
Strong Sell000000
Total131413121212

Financial Forecast

Revenue This Year
16.74B
from 14.10B
Increased by 18.77%
Revenue Next Year
19.23B
from 16.74B
Increased by 14.89%
EPS This Year
1.01
from 0.87
Increased by 15.81%
EPS Next Year
1.38
from 1.01
Increased by 36.78%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Jan 1, 2023Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
7.44B10.27B11.54B12.28B14.10B16.74B
Revenue Growth
45.00%37.92%12.39%6.39%14.82%18.77%
Gross Profit
2.68B3.76B4.12B4.18B4.89B5.93B
Gross Margin
35.95%36.67%35.67%34.09%34.70%35.44%
Operating Income
1.45B1.67B1.69B1.72B2.05B2.43B
Net Income
1.66B1.37B1.60B1.79B1.66B1.95B
EPS
----0.871.01
EPS Growth
----38.72%15.81%
Forward PE
59.2335.7525.7226.2224.7247.71
Dividend / Share
0.200.200.200.200.200.24
Dividend Growth
50.04%----21.79%
Free Cash Flow
-479.46M-1.68B-1.46B11.95M-327.62M247.67M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High16.9B
Avg16.7B
Low16.6B

Revenue Growth

Revenue Growth202620272028
High
20.3%
Avg
18.8%
Low
17.7%

EPS Forecast

EPS202620272028
High1.01
Avg1.01
Low1.01

EPS Growth

EPS Growth202620272028
High
15.8%
Avg
15.8%
Low
15.8%